1. Home
  2. Live Updates
  3. Johnathan napier

Live Breaking News & Updates on Johnathan napier

Stay informed with the latest breaking news from Johnathan napier on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Johnathan napier and stay connected to the pulse of your community

Viewpoint: While African nations embrace GM and gene-edited crops to address climate change challenges, EU lags further behind, even as food prices soar

While some richer nations dither over how to deal with biotech farming innovations, scientists in lower and middle income countries are seizing the opportunity to give agriculture a targeted genomic reboot.

Johnathan-napier , Rothamsted-research , United-kingdom-based ,

Will England emerge as a world innovator in gene-edited crops?

Brexit has been a disaster for the UK.  It has not spurred the great economic revival that many of the Brexiters claimed it would. And many studies have indicated it will make the UK poorer over the long-term and deter investment. 

Argentina , London , City-of , United-kingdom , Brazil , Edinburgh , Cambridge , Cambridgeshire , Israel , Canada , Pirbright , Surrey

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q3 2023 Earnings Call Transcript

Operator: Hello and welcome to the Third Quarter 2023 Financial Results and Business Update Conference Call for Yield10 Bioscience.

United-states , Idaho , Norway , Canada , Montana , Rothamsted , Hertfordshire , United-kingdom , Chile , Peace-river , Alberta , Peru

Yield10 sees 'significant market opportunities' for camelina derived omega-3 fatty acids

Yield10 Bioscience says it has exercised its option to finalize a global, commercial license to advanced omega-3 production technology from UK based Rothamsted Research.

United-states , Massachusetts , America , Johnathan-napier , Biotechnology-regulatory-services , Professor-johnathan-napier , South-america , Regulatory-services , Suppliers , Ustainability , Urope , Orth-america

Omega-3 GM Camelina hits new commercialisation milestone

Yield10 Bioscience has signed a deal that will give it the exclusive licence to sell Omega-3 oils from the genetically modified

United-states , Peru , America , Johnathan-napier , Biotechnology-regulatory-services , Professor-johnathan-napier , Oliver-peoples , South-america , Status-review , Regulatory-services ,

Yield10 Bioscience (YTEN) Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research

Yield10 Bioscience (YTEN) Exercises Option to Finalize an Exclusive, Global Commercial License to Advanced Omega-3 Camelina Technology from Rothamsted Research
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Peru , United-states , America , Johnathan-napier , U-rothamsted-research-limited , Biotechnology-regulatory-services , Bioscience-inc , Rothamsted-flagship-program , Nasdaq , Rothamsted-research-limited , Flagship-program , Professor-johnathan-napier

Yield10 Exercises Options | MENAFN.COM

Yield10 Exercises Options | MENAFN.COM
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Johnathan-napier , Rothamsted-flagship-program , U-rothamsted-research-limited , Nasdaq , Bioscience-inc , Flagship-program , Professor-johnathan-napier , Science-director ,

Headline news roundup: September 2023

From WHO fighting infant formula marketing to enhanced botanical bioavailability with fermentation, September’s news roundup covers the latest developments in health, nutrition, and regulatory changes.


United-kingdom , Rothamsted , Hertfordshire , Johnathan-napier , James-collier , Kremlin-wickramasinghe , Health-food-supplements-information-service , Researchers-at-rothamsted-research , World-health-organisation , European-commission , Natural-algae-astaxanthin-association , Europe-regional-adviser

"There's not plenty more fish in the sea" but GM crop is ripe for commercialisation

Researchers working to bring a sustainable source of omega-3 oil to market have reached a significant milestone in achieving scaled-up production of a genetically modified camelina seed oil.

United-states , Rothamsted , Hertfordshire , United-kingdom , Massachusetts , America , Johnathan-napier , Rothamsted-research-in-harpenden , Reading-university , University-of-southampton , Professor-johnathan-napier , Rothamsted-research

"There's not plenty more fish in the sea" but GM crop is ripe for commercialisation

Researchers working to bring a sustainable source of omega-3 oil to market have reached a significant milestone in achieving scaled-up production of a genetically modified camelina seed oil.

Rothamsted , Hertfordshire , United-kingdom , Massachusetts , United-states , America , Johnathan-napier , University-of-southampton , Bioscience-inc , Rothamsted-research-in-harpenden , Reading-university , Professor-johnathan-napier